What is the real and latest price of a box of fotantinib/fotantinib?

Fostamatinib is a targeted therapy drug whose application is mainly focused on the treatment of chronic immune thrombocytopenia (ITP), especially for adult patients who have poor response to traditional treatments. Fotantinib is available in two main specifications: 100 mg 60 tablets and 150 mg 60 tablets. However, because its original version has not yet been launched in the Chinese market, the specific price and medical insurance policy are still unclear, which makes patients face certain challenges when obtaining the drug.

In overseas markets, especially Germany, the original drug of fotantinib is already available for purchase, with prices ranging from RMB 20,000 to RMB 40,000. This price range is often affected by a variety of factors, including exchange rate fluctuations, drug import taxes, sales channels, and local medical insurance policies. Therefore, patients need to pay attention to these factors that may affect the final cost when considering a purchase.

Due to the high price of fotantinib, many patients may feel a greater financial burden. Therefore, it is particularly important to understand the medical insurance coverage of drugs and possible funding programs. At present, generic drugs for fotantinib have not yet been launched overseas and domestically, which also limits patients' choice of treatment options. Although more related products may be released in the future as research continues to deepen, at this stage, the high price of fotantinib is still a reality that cannot be ignored.

When patients choose whether to use fotantinib, they must not only consider the efficacy of the drug, but also evaluate their own financial situation and drug accessibility. When faced with high drug prices, patients and doctors can jointly explore other possible treatment options to ensure that the patient's financial burden is reduced while ensuring efficacy.

Reference materials:https://go.drugbank.com/drugs/DB12010